Chesapeake Wealth Management Amgen Inc Transaction History

Chesapeake Wealth Management

$273 Million
Q1 2024

A detailed history of Chesapeake Wealth Management transactions in Amgen Inc stock. As of the latest transaction made, Chesapeake Wealth Management holds 3,893 shares of AMGN stock, worth $1.23 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

3,893

Previous 4,018 3.11%

Holding current value

$1.23 Million

Previous $1.16 Million 4.41%

% of portfolio

0.4%

Previous 0.45%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$268.87 - $324.56 $33,608 - $40,570	-125 Reduced 3.11%	3,893 $1.11 Million
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $14,063 - $15,865	-55 Reduced 1.35%	4,018 $1.16 Million
Q3 2023 Nov 16, 2023	SELL	$218.65 - $271.46 $22,302 - $27,688	-102 Reduced 2.44%	4,073 $1.09 Million
Q2 2023 Aug 01, 2023	SELL	$214.27 - $253.37 $16,070 - $19,002	-75 Reduced 1.76%	4,175 $926,000
Q1 2023 Apr 25, 2023	SELL	$225.79 - $275.2 $8,354 - $10,182	-37 Reduced 0.86%	4,250 $1.03 Million

Q3 2022 Oct 28, 2022	SELL	$224.46 - $253.15 $11,447 - $12,910	-51 Reduced 1.18%	4,287 $966,000
Q2 2022 Jul 21, 2022	SELL	$230.71 - $256.74 $7,844 - $8,729	-34 Reduced 0.78%	4,338 $1.06 Million
Q1 2022 Apr 19, 2022	SELL	$219.27 - $242.57 $29,382 - $32,504	-134 Reduced 2.97%	4,372 $1.06 Million
Q4 2021 Feb 03, 2022	SELL	$198.88 - $227.6 $71,596 - $81,936	-360 Reduced 7.4%	4,506 $1.01 Million
Q3 2021 Oct 26, 2021	SELL	$212.27 - $248.7 $278,073 - $325,797	-1,310 Reduced 21.21%	4,866 $1.03 Million
Q2 2021 Jul 29, 2021	SELL	$233.58 - $259.14 $103,008 - $114,280	-441 Reduced 6.66%	6,176 $1.51 Million
Q1 2021 Apr 26, 2021	SELL	$221.91 - $258.6 $56,143 - $65,425	-253 Reduced 3.68%	6,617 $1.65 Million
Q4 2020 Feb 05, 2021	SELL	$216.38 - $257.67 $34,188 - $40,711	-158 Reduced 2.25%	6,870 $1.58 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $13,375 - $14,874	-57 Reduced 0.8%	7,028 $1.79 Million
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $791 - $970	-4 Reduced 0.06%	7,085 $1.67 Million
Q1 2020 Apr 29, 2020	BUY	$182.24 - $241.7 $140,871 - $186,834	773 Added 12.24%	7,089 $1.44 Million
Q4 2019 Jan 29, 2020	SELL	$189.21 - $243.2 $7,568 - $9,728	-40 Reduced 0.63%	6,316 $1.52 Million
Q3 2019 Oct 25, 2019	BUY	$174.11 - $208.62 $2,089 - $2,503	12 Added 0.19%	6,356 $1.23 Million
Q2 2019 Aug 01, 2019	SELL	$166.7 - $195.41 $382,243 - $448,075	-2,293 Reduced 26.55%	6,344 $1.17 Million
Q1 2019 Apr 17, 2019	BUY	$180.87 - $203.88 $98,212 - $110,706	543 Added 6.71%	8,637 $1.64 Million
Q4 2018 Feb 06, 2019	BUY	$178.4 - $208.25 $280,623 - $327,577	1,573 Added 24.12%	8,094 $1.58 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $21,308 - $24,022	-115 Reduced 1.73%	6,521 $1.35 Million
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $23,579 - $26,484	-142 Reduced 2.1%	6,636 $1.23 Million
Q1 2018 Jun 04, 2018	BUY	$169.43 - $198.0 $1.15 Million - $1.34 Million	6,778 New	6,778 $1.16 Million

Others Institutions Holding AMGN

# of Institutions

2,936

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesapeake Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Chesapeake Wealth Management with notifications on news.

Account

Chesapeake Wealth Management Amgen Inc Transaction History